Patient-specific measures of a biomarker for the generation of individual reference intervals: Hemoglobin as example

Translational Research

Volumn 158, Issue 6, 2011, Pages 360-368

  Sottas, Pierre Edouard ^a   Kapke, Gordon F ^b   Vesterqvist, Ole ^b   Leroux, Jean Marc ^a  

^a Labcorp Drug Development   (Switzerland)

^b Labcorp Drug Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRUG; HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BAYES THEOREM; CHILD; DEMOGRAPHY; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 80755125988     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.08.005     Document Type: Article

References (18)

1. C.G. Fraser Biologic variation: principles and practice 2001 AACC Press Washington DC
2. C.G. Fraser Inherent biological variation and reference values Clin Chem Lab Med 42 2004 758 764 (Pubitemid 39137225)
3. E.K. Harris Effects of intra and interindividual variation on the appropriate use of normal ranges Clin Chem 20 1974 1535 1542
4. P.E. Sottas, N. Baume, and C. Saudan Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio Biostatistics 2 2007 285 296 (Pubitemid 46569590)
5. P.E. Sottas, N. Robinson, and M. Saugy The athlete's biological passport and indirect markers of blood doping D. Thieme, P. Hemmersbach, Doping in sports (Handbook of experimental pharmacology, vol. 195) 2010 Springer Berlin, Germany
6. C. Ricós, V. Alvarez, and F. Cava Current databases on biologic variation: pros, cons and progress Scand J Clin Lab Invest 59 1999 491 500 (Pubitemid 30056739)
7. C. Ricós, N. Iglesias, and J.V. García-Lario Within-subject biological variation in disease: collated data and clinical consequences Ann Clin Biochem 44 2007 343 352
8. Available at: http:// www.fda.gov/downloads/ScienceResearch/ SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/UCM077254. pdf. Accessed June 21, 2011.
9. R.T. O'Neill FDA's critical path initiative: a perspective on contributions of biostatistics Biom J 48 2006 559 564 (Pubitemid 44367895)
10. P.E. Sottas, N. Robinson, O. Rabin, and M. Saugy The athlete biological passport Clin Chem 57 2011 969 976
11. D.A. Berry Bayesian clinical trials Nat Rev Drug Discov 5 2006 27 36
12. K. Sharpe, W. Hopkins, and K.R. Emslie Development of reference ranges in elite athletes for markers of altered erythropoiesis Haematologica 87 2002 1248 1257 (Pubitemid 36005299)
13. M. Heins, B. Schossow, L. Greiner, and W. Heil Influence of storage time and temperature on haematological measurands using a Sysmex NE 8000 analyser J Lab Med 24 2000 236 242 (Pubitemid 30316130)
14. G.M.P. Costongs, P.C.W. Janson, and B.M. Bas Short-term and long-term intra-individual variations and critical differences of haematological laboratory parameters J Clin Chem Clin Biochem 23 1985 69 76 (Pubitemid 15140776)
15. A.C. Looker, C.T. Sempo, and K. Liu Within-person variance in biochemical indicators of iron status: effects on prevalence estimates Am J Clin Nutr 52 1990 541 547 (Pubitemid 20260632)
16. D. Dot, J. Miró, and X. Fuentes Within-subject biological variation of hematological quantities and analytical goals Arch Pathol Lab Med 116 1992 825 826
17. C.G. Fraser, S.P. Wilkinson, and R.G. Neville Biologic variation of common hematologic laboratory quantities in the elderly Am J Clin Pathol 92 1989 465 470 (Pubitemid 19248346)
18. L.A. Nunes, R. Brenzikofer, and D.V. de Macedo Reference change values of blood analytes from physically active subjects Eur J Appl Physiol 110 2010 191 198